- Home
- Publications
- Publication Search
- Publication Details
Title
HDL and Cardiovascular Risk
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 111, Issue 9, Pages 1117-1120
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-10-12
DOI
10.1161/circresaha.112.280958
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies
- (2012) Stephen J. Nicholls et al. CARDIOVASCULAR DRUGS AND THERAPY
- Is niacin ineffective? Or did AIM-HIGH miss its target?
- (2012) S. J. NICHOLLS CLEVELAND CLINIC JOURNAL OF MEDICINE
- Rationale for cholesteryl ester transfer protein inhibition
- (2012) Bernd Hewing et al. CURRENT OPINION IN LIPIDOLOGY
- Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
- (2012) Thomas F. Lüscher et al. EUROPEAN HEART JOURNAL
- Mendelian randomisation, lipids, and cardiovascular disease
- (2012) Seamus C Harrison et al. LANCET
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
- (2011) R. S. Rosenson et al. CLINICAL CHEMISTRY
- LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals
- (2011) Christiane L. Haase et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
- (2011) Katey J. Rayner et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease
- (2011) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
- (2011) Katey J. Rayner et al. NATURE
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells
- (2011) J. E. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetically Elevated Apolipoprotein A-I, High-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease
- (2010) Christiane L. Haase et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High-density lipoprotein therapeutics and cardiovascular prevention
- (2010) Sergio Fazio et al. Journal of Clinical Lipidology
- RVX-208
- (2010) Dana Bailey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
- (2010) Ron Waksman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
- (2009) Gregory G. Schwartz et al. AMERICAN HEART JOURNAL
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
- (2008) James A. Shaw et al. CIRCULATION RESEARCH
- The HDL proteome: a marker–and perhaps mediator–of coronary artery disease: Fig. 1.
- (2008) Jay W. Heinecke JOURNAL OF LIPID RESEARCH
- High-Density Lipoprotein Cholesterol, High-Density Lipoprotein Particle Size, and Apolipoprotein A-I: Significance for Cardiovascular Risk
- (2008) Wim A. van der Steeg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dose-Related Effects of Repeated ETC-216 (Recombinant Apolipoprotein A-IMilano/1-Palmitoyl-2-Oleoyl Phosphatidylcholine Complexes) Administrations on Rabbit Lipid-Rich Soft Plaques
- (2008) Cinzia Parolini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rapid regression of atherosclerosis: insights from the clinical and experimental literature
- (2008) Kevin Jon Williams et al. Nature clinical practice. Cardiovascular medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now